MEDTRONIC PUERTO RICO OPERATIONS CO. PUMP MMT-1711KL 640G V4.10 BK SF MM; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR
|
Back to Search Results |
|
Model Number MMT-1711KL |
Device Problem
Excess Flow or Over-Infusion (1311)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/10/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4).The insulin pump involved in this event is the 640g insulin infusion pump, which is not marketed in the united states.However, the device is similar to the paradigm real-time insulin infusion pump, which is marketed in the united states.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Information received by medtronic indicated that the pump had delivered extra during basal, and that caused the blood glucose value to drop below expected range according to the customer.The customer had a low blood glucose level of 3.2 mmol/l.Which was treated by glucose tablets.The customer was using the insulin pump with automode feature on within 48 hours of the reported adverse event.No additional consequences requiring medical intervention were reported.The customer was assisted with troubleshooting.The customer will discontinue to use the device.The insulin pump will be returned for the product analysis.
|
|
Event Description
|
The insulin pump was returned for analysis.
|
|
Manufacturer Narrative
|
Additional information has been received which was not included with the initial report.The information has been provided in section b5 with this report.This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Retainer ring = black.Case = ngp.Customer returned pump for alleged over delivering and experiencing low bg observed on 10-oct-2022.Unit passed active current measurement, sleep current measurement test, self-test, rewind, seating, basic occlusion test, occlusion test, force sensor test and displacement test.Unit passed dat test at (.08695) inches.No over delivery anomalies noted during testing.Unit successfully downloaded to thus and carelink.Confirmed 120.5 units of normal bolus was delivered on oct/10/2022 between 03:58:59.000 and 23:20:30.000.The electronic assemblies and motor assemblies were inspected and no anomalies noted.The following were noted during visual inspection: scratched case, pillowing keypad overlay, cracked keypad overlay, stained keypad overlay, serial number label missing, and cracked battery tube threads.The p-cap/reservoir does lock properly.Pump passed functional testing and no over delivery anomalies noted during testing.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|